Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Metronidazole as a radiosensitizer: a preliminary report on estimation in serum and saliva

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6879682
Some studies indicate the clinical benefit of hypoxic radiosensitizers in patients who are undergoing radiotherapy. Serum level of sensitizers are usualy advised; however they are very demanding on the patient. Saliva level of the sensitizers may be an alternative method. This study correlated serum level of metronidazole to the saliva level in 10 patients who were undergoing radiotherapy with the sensitizer. A change to the saliva level method appears to relieve the patients.
Research Organization:
Free Univ., Amsterdam, Netherlands
OSTI ID:
6879682
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 6:9
Country of Publication:
United States
Language:
English